Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Saliva Diagnostics (SALV) -- Ignore unavailable to you. Want to Upgrade?

To: Keiko who wrote (1813)	12/7/1997 7:43:00 PM
From: Bruce Rozenblit	Respond to of 3369

We have been chopped to bits!

To: Keiko who wrote (1813)	12/9/1997 10:37:00 AM
From: John Lacelle	Respond to of 3369

Hey Keiko, Thanks for the warning on the "Chop Stocks". I myself have watched many friends and relatives fall victim to scams like that. Don't worry about me...I am paranoid to the point of not even trusting my on line broker, and its a computer! I even get an occasional cold- call from some scamster. I always have fun turning the tables on them. I think the most interesting point about the recent scam on the NASDAQ listed GYMM, was that usually these scams are usually carried out with OTC stocks that can be easily manipulated. GYMM was manipulated using everyone from the Gambino Crime Family in New York to the company president himself. Even stranger is that it was a fairly successful company to begin with...why scam when you can make money the old fashioned way? My biggest problem with stock scams are that some of them are quite legal. I ranted and raved quite a bit here recently about how the biotech industry is rife with these IPO's which go public with zero earnings, and make all these foward looking statements about cures for this disease or that, all the while indicating the potential windfall profits to be made. If anyone doubts my assertion that most of these biotech IPO's are losers, just check out the list of companies listed as 52 week lows, or penny stocks, or 4 week losers and the such. You will see that most of them are biotechs that have been around for a few years. Its funny how these biotechs with zero earnings manage to pay their officers salaries of $200,000 a year. -John